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ABSTRACT
The cardiac voltage-gated sodium channel Nav1.5 conducts the rapid inward sodium current
crucial for cardiomyocyte excitability. Loss-of-function mutations in its gene SCN5A are linked to
cardiac arrhythmias such as Brugada Syndrome (BrS). Several BrS-associated mutations in the Nav
1.5 N-terminal domain (NTD) exert a dominant-negative effect (DNE) on wild-type channel
function, for which mechanisms remain poorly understood. We aim to contribute to the under-
standing of BrS pathophysiology by characterizing three mutations in the Nav1.5 NTD: Y87C–here
newly identified–, R104W, and R121W. In addition, we hypothesize that the calcium sensor protein
calmodulin is a new NTD binding partner. Recordings of whole-cell sodium currents in TsA-201
cells expressing WT and variant Nav1.5 showed that Y87C and R104W but not R121W exert a DNE
on WT channels. Biotinylation assays revealed reduction in fully glycosylated Nav1.5 at the cell
surface and in whole-cell lysates. Localization of Nav1.5 WT channel with the ER did not change in
the presence of variants, as shown by transfected and stained rat neonatal cardiomyocytes. We
demonstrated that calmodulin binds the Nav1.5 NTD using in silico modeling, SPOTS, pull-down,
and proximity ligation assays. Calmodulin binding to the R121W variant and to a Nav1.5 construct
missing residues 80–105, a predicted calmodulin-binding site, is impaired. In conclusion, we
describe the new natural BrS Nav1.5 variant Y87C and present first evidence that calmodulin
binds to the Nav1.5 NTD, which seems to be a determinant for the DNE.
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Brugada syndrome (BrS) is a genetic cardiac arrhyth-
mia, affecting 1 in 2000 people worldwide[1], mostly
men with structurally normal hearts [2,3]. BrS is
characterized by an ST-segment elevation in the
right precordial ECG leads without evidence of
ischemia, and patients are at increased risk of ven-
tricular fibrillation and sudden cardiac death [4].
Approximately 20% of BrS cases are associated with
mutations in SCN5A, the gene encoding the voltage-
gated sodium channel Nav1.5 [5].
Nav1.5 is crucial for cardiac excitability as it
conducts a rapid inward depolarizing sodium cur-
rent (INa) in cardiomyocytes, shaping the rapid
upstroke of the action potential [6]. BrS-
associated SCN5A pathogenic variants typically
confer a loss of Nav1.5 function by affecting chan-
nel gating or trafficking, slowing the action poten-
tial upstroke and cardiac conduction [7]. In
addition, several BrS variant channels confer
a dominant-negative effect (DNE) in cellular
expression systems. The DNE is defined as nega-
tive regulation of WT channels by variant channels
[8]. As such, when variant and wild-type channels
are co-expressed in cells, the peak sodium current
(INa) is less than 50% of that in wild-type condi-
tions. The first SCN5A BrS variant conferring
a DNE (L325R) was described by Keller et al. [9].
Since then, several variant channels in the Nav
1.5 N-terminus domain (NTD) have been shown
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to exert a DNE on WT channels, including R104W
and R121W [10,11].
The mechanisms underlying the DNE of NTD
Nav1.5 variants remain unknown. Channel–chan-
nel interactions seem to be crucial for the DNE
phenomenon, which is likely mediated by Nav1.5
interacting proteins [10,12]. Only when we iden-
tify molecular mediators of the DNE at the NTD,
we can explain the functional heterogeneity of
NTD variants and ultimately identify therapeutic
targets for BrS patients. In this study, we aim to
elucidate the mechanisms underlying the DNE of
the three N-terminal mutants Y87C, R104W, and
R121W. We hypothesize that the calcium-binding
protein calmodulin (CaM) is a yet-unknown
N-terminal interaction partner. CaM is well-
known to regulate voltage-gated sodium (Nav)
and calcium (Cav) channel functions [13,14]. Its
interactions with Nav and Cav C-terminal domains
(CTD) are especially well-established [13,15]. In
the Cav1.2 NTD, two CaM binding sites have
been described [16,17], while CaM interaction
with the Nav1.5 NTD remains unexplored.
Here, in BrS probands of a Russian family, we
identify the new Nav1.5 NTD variant Y87C, which
exerts a DNE on WT channel function. Using the
TsA-201 cell expression system in patch-clamp
and biochemistry experiments, we confirm
R104W exerts a DNE, but R121W surprisingly
does not. CaM is identified as a new Nav
1.5 N-terminal binding partner. CaM binds WT,
Y87C, and R104W NTDs, but only weakly to
R121W NTD and NTD lacking amino acids
80–105. As such, the ability of CaM to bind the
Nav1.5 NTD correlates with the occurrence of the
DNE. Lastly, we show a reduction in fully glyco-
sylated bands of all three Nav1.5 variants com-




We obtained the informed consent from probands
and their family members for genetic investiga-
tions in accordance with the Helsinki declaration.
For the SCN5A gene, coding and adjacent intronic
areas were sequenced using PCR-based bi-
directional Sanger sequencing. The prevalence of
the rare genetic variant c.206A>G(Y87C) was
determined using allele-specific PCR in an ethni-
cally matched group of 150 healthy volunteers, and
in the public database gnomAD (https://gnomad.
broadinstitute.org/). Pathogenicity assessment was
performed in accordance with ACMG guidelines
(2015) [18]. The potential effect of the variant was
tested in silico using PolyPhen2.0 (http://genetics.
bwh.harvard.edu/pph2/), Provean (http://provean.
jcvi.org/), and MutationTaster (http://www.muta
tiontaster.org/) tools.
cDNA constructs, cell culture, and transfections
In the cDNA templates pcDNA3.1-SCN5A-WT,
pcDNA3.1-S-tag-SCN5A-WT-NTD (a kind gift
from Dr. Nathalie Neyroud, INSERM, Paris,
France), and pcDNA3.1–3X-FLAG-SCN5A-WT,
the following Nav1.5 variants were introduced
(GenScript, NJ, USA): Y87C, R104W, R121W,
and Δ26, in which amino acid residues 80–105
were deleted. S-tag-SCN5A-WT-NTD encodes
the 131-amino-acid-long Nav1.5 NTD. The Cav
1.2-WT-NTD and the homologous Cav
1.2-R144W-NTD constructs were generated by
replacing the SCN5A sequence in the
pcDNA3.1-S-tag-SCN5A-WT-NTD cDNA with
the Cav1.2 NTD sequence. Nav1.5-encoding
cDNA corresponded to the transcript
NM_000335.5 (human; Genbank) with the
amino acid variant T559A, for which no func-
tional consequences have been reported. Cav
1.2-encoding cDNA corresponded to X15539.1
(cardiac isoform, rabbit; Genbank). Primers
designed for mutagenesis are available upon
request. All cDNAs were validated by
sequencing.
We obtained human embryonal kidney (TsA-
201) and monkey kidney cells (COS) from the
American Type Culture Collection (ATCC, VA,
USA). Cells were cultured at 37°C with 5% CO2
in Dulbecco’s modified Eagle’s culture medium
(Gibco, Thermo Fisher Scientific, MA, USA),
which we supplemented with 2 mM glutamine
and 10% heat-inactivated fetal bovine serum.
Cells were kept in culture up to 20 passages for
experimental use. All transfections were per-
formed with JET PEI (Polyplus Transfection,
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Illkirch, France) following the manufacturer’s
instructions.
For electrophysiological recordings, we cultured
TsA-201 cells in 35 mm petri dishes. We trans-
fected cells with 128 ng SCN5A cDNA to mimic
a non-saturated homozygous state. To mimic the
heterozygous state, cells were co-transfected with
64 ng pcDNA3.1-SCN5A-WT and 64 ng of
a pcDNA3.1-SCN5A variant (Y87C, R104W,
R121W, or Δ26) or empty vector
(pCDNA3.1-Zeo(+)). All transfections additionally
contained 64 ng pIRES-hβ1-CD8 cDNA, encoding
the human sodium channel β1-subunit and the
CD8 receptor.
For biochemical experiments, we cultured TsA-
201 cells in 100 mm petri dishes. To assay cell
surface biotinylation, we transfected cells with
768 ng pcDNA3.1-SCN5A-WT or one of the
selected variants, and 364 ng pIRES-hβ1-CD8.
For calmodulin pull-down experiments, we trans-
fected cells with 2 μg pcDNA3.1-S-tag-SCN5A-WT
-NTD or one of the selected variants.
For proximity ligation assays (PLAs), we cul-
tured COS cells in µ-Slide 8-Well Grid-500
ibiTreat (ibidi, Gräfelfing, Germany) and trans-
fected them with 120 ng pcDNA3.1-S-tag-SCN5A-
WT-NTD, one of the variants (Y87C, R104W,
R121W, or Δ26), or empty vector.
Rat neonatal cardiomyocyte isolation, culture,
and transfection
All institutional experimental guidelines for ani-
mal handling were met. The Veterinary Office of
the Canton of Bern, Switzerland, approved our
experiments. We isolated primary rat neonatal
cardiomyocytes (RNCs) and cultured them at 37°
C with 1% CO2[19]. RNCs were seeded on lami-
nin-coated (Sigma, MO, USA) µ-Slide 8-Well
Grid-500 ibiTreat dishes (ibidi). Cells were trans-
fected 24 h after cell seeding using Lipofectamine
3000 (Invitrogen, CA, USA). To study the subcel-
lular localization of Nav1.5 full-length channels in
the homozygous state, we transfected RNCs with
400 ng pcDNA3.1–3X-FLAG-SCN5A-WT or one
of the variants Y87C, R104W, or R121W. To study
their subcellular localization in the heterozygous
state, we transfected RNCs with 200 ng
pcDNA3.1-GFP-SCN5A-WT and 200 ng of one
of the variants. All conditions additionally con-
tained 100 ng pDsRed2-ER (Takara Clontech,
Kusatsu, Japan) as an endoplasmic reticulum
(ER) marker.
Calmodulin-binding prediction
To computationally predict CaM binding to Nav
1.5 NTD, we used the CaM target database (http://
calcium.uhnres.utoronto.ca/ctdb/ctdb/sequence.
html). Scores are normalized on a scale from 0 to




Peptides were synthesized using standard 9-fluor-
enylmethoxy carbonyl (Fmoc) protected and acti-
vated amino acids (Anaspec, CA, USA) on
prederivatized cellulose membranes (Intavis AG,
Cologne, Germany) using an Intavis robot [20].
Human Nav1.5 (Q14524 (SCN5A_Human) iso-
form 1) N-terminal domain 1–131 was tiled as 15
amino acid peptides with a 13-amino acid overlap
(two amino acids skipped between consecutive
peptides). The membrane was briefly wet with
dimethylformamide (DMF) and peptides were
labeled with bromophenol blue (1%) for annota-
tion of the array pattern at the completion of
synthesis as described previously [20,21]. The pep-
tides on the array were then de-protected with two
washes of 88% trifluoroacetic acid, 2% triisopro-
pylsilane, 5% phenol, and 5% water, for 90 min
each at room temperature. Each de-protection step
was followed by three washes with dichloro-
methane, three washes with DMF, and three
washes with ethanol and the membranes dried.
Before binding experiments, the membrane was
wet by exposure to ethanol for 15 min, followed
by DMF for 15 min and three 15 min washes with
phosphate-buffered saline (PBS), all while shaking
at room temperature. The hydrated membrane
was then equilibrated for 30 min in 20 mM Tris-
HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, and
0.1% Tween-20, before the membrane was blocked
in the same buffer plus 5% bovine serum album
(BSA) for 30 min. The binding buffer used in the
CaM binding reaction was identical to membrane
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equilibration buffer, except 5 mM EGTA was
included in the buffer along with 100 nM of
DyLight680-labeled CaM; mutant Cys-75 CaM
purified as described previously [22,23] and
labeled with a sulfhydryl reactive maleimide fluor-
ophore as described by the manufacturer (Fisher
#46618). After 5 min at room temperature, the
apoCaM binding reaction was washed in binding
buffer (3 × 15 min including plus 5 mM EGTA)
before the membrane was imaged using a Li-Cor
Imaging Station (Li-Cor Biosciences, Bad
Homberg, Germany).
Cell surface biotinylation assay
We used a cell surface biotinylation assay to study
protein expression at the plasma membrane. 48 h
after transfection, TsA-201 cells transiently expressing
Nav1.5 constructs were supplied with 0.5 mg/mL EZ-
link™ Sulfo-NHS-SS-Biotin (Thermo Fisher Scientific)
in PBS for 15 min at 4°C. Then, we washed the cells
twice with 200 mM glycine in cold PBS to inactivate
and remove excess biotin, respectively. Cells were
taken up in lysis buffer (composed of [mM] HEPES
50 pH 7.4, NaCl 150, MgCl2 1.5, EGTA 1 pH 8; 10%
glycerol, 1% Triton X-100 (Tx100), complete protease
inhibitor [Roche, Basel, Switzerland]) for 1 h at 4°C.
Cell lysates were centrifuged at 16,100 rcf at 4°C for
15 min. We determined protein concentration of the
supernatant with Bradford assay (Bio-Rad) [24], and
incubated lysate equivalent to 2 mg of protein with
50 μL Streptavidin Sepharose High-Performance
beads (GE Healthcare, IL, USA) for 2 h at 4°C, then
washed the beads three times with lysis buffer, and
eluted them with 30 μL of 2X NuPAGE sample buffer
plus 100 mMDTT (37°C for 30 min). Input fractions
were resuspended in NuPAGE Sample Buffer
(Invitrogen) plus 100 mM dithiothreitol (DTT) and
incubated at 37°C for 30 min.
Calmodulin pull-down assay
Weused the calmodulin pull-down assay to determine
whether Nav1.5 and Cav1.2 constructs bind calmodu-
lin. 48 h after transfection, TsA-201 cells were lysed in
lysis buffer with 100 nM free Ca2+ for 1 h at 4°C. The
free Ca2+ concentration was calculated based on an
established method [25]. Lysed samples were centri-
fuged at 16,100 rcf at 4°C for 15 min. We quantified
supernatant protein concentration with the Bradford
assay. After washing calmodulin and control
Sepharose 4B beads (GE Healthcare) twice with lysis
buffer, we mixed lysate corresponding to 60, 180, or
540 μg protein with the beads. Beads and lysate mix-
ture incubated at 4°C on a wheel for 3 hours. We
washed the beads three times with lysis buffer and
eluted proteins from the beads in 30 µL 2X NuPAGE
sample buffer with 100 mM DTT at 55°C (15 min).
SDS-Page and western blot
Protein samples were loaded on pre-casted 4–12%
Bis-Tris acrylamide gradient gels (Invitrogen), run
at 60 V for 30 min and at 200 V for 45–120 min,
and transferred to nitrocellulose membranes (Bio-
Rad, CA, USA) with the TurboBlot dry blot system
(Bio-Rad). Western blots were performed with the
SNAP i.d. system (Millipore, Zug, Switzerland).
Briefly, membranes were blocked with 1% BSA,
incubated with primary antibodies diluted in PBS
+ 0.1% Tween20 for 10 minutes, washed four
times with PBS + 0.1% Tween20, incubated with
secondary antibodies diluted in PBS + 0.1%
Tween20, washed again four times with PBS +
0.1% Tween20 and three times with PBS.
Fluorescent signals were detected on an Odyssey
infrared imaging system (Li-Cor). We determined
protein content by quantifying band fluorescence
densities with the Image Studio Lite software ver-
sion 5.2 (Li-Cor).
The following primary antibodies detected the
proteins of interest: mouse anti-α-CaMKII (1:3000;
BD, NJ, USA; 611292); rabbit anti-α-actin (1:3000,
Sigma, A2066); mouse anti-S-tag (1:1500, Sigma,
SAB2702204); rabbit anti-Nav1.5 (1:150, generated
by Pineda, Berlin, Germany); and mouse anti-
alpha-1 sodium-potassium ATPase (1:3000;
Abcam, Cambridge, UK; ab7671). Secondary
IRDye® antibodies (Li-Cor) were 680RD goat anti-
mouse (1:15000; 926–68070), 800CW goat anti-
mouse (1:15000; 926–32210), and 800CW goat
anti-rabbit (1:15000, 925–32211).
Quantitative real-time PCR (RT-qPCR)
We isolated total RNA from TsA-201 cells transiently
expressing pcDNA3.1-hSCN5A-WT, Y87 C, R104W,
R121 W, or Δ26 with TRIzol reagent (Invitrogen)
following the manufacturer’s instructions. We used
2 µg RNA for reverse transcription with the High-
Capacity cDNA Reverse Transcription Kit (Applied
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Biosystems, CA, USA). The cDNA was diluted (1:10)
in H2O for qPCR with the TaqMan Gene Expression
Assay (Applied Biosystems). qPCR conditions in the
ViiA 7 Real-Time PCR System (Thermo Fisher
Scientific) were as follows: activation 2 min at 50°C;
hold 20 s at 95°C; 40 cycles of denaturation 3 s at 95°C
and annealing 60 s at 60°C. We normalized the
expression levels of human SCN5A
(HS00165693_m1) to the reference gene GAPDH
(HS99999905_m1), and then to the SCN5A WT
expression using the 2−ΔΔCt method [26].
Electrophysiological recordings
Whole-cell currents were recorded 48 hours after
transfection using the patch-clamp technique with
an Axopatch 200B amplifier (Molecular Devices,
Wokingham, United Kingdom) at room tempera-
ture (25 ± 1°C)[27]. The recorded INa was filtered
at 5 kHz by a low-pass filter (HumBug, Quest
Scientific, BC, Canada) at a sampling rate of
20 kHz per signal. Leak current subtraction was
applied with a P/4 protocol. We used the DMZ-
universal puller (program 10, Zeitz, Martinsried,
Germany) to pull the patch pipettes (World
Precision Instruments, Friedberg, Germany) to
a resistance of 2.0 to 4.5 MΩ. The internal pipette
solution contained (mM) CsCl 60, aspartic acid 50,
CaCl2 1, MgCl2 1, HEPES 10, EGTA 11, Na2ATP 5.
pH was adjusted to 7.2 with CsOH. The external
solution contained (mM) NaCl 25, NMDG-Cl 105,
CsCl 5, CaCl2 2, MgCl2 1.2, HEPES 10, glucose 20.
pH was adjusted to 7.4 with HCl.
We used the voltage clamp mode to obtain cur-
rent–voltage relationships (I–V curves). Sodium cur-
rent density (pA/pF) was calculated by dividing peak
current by cell capacitance using the Axon™
pCLAMP™ 10 Electrophysiology Data Acquisition &
Analysis Software, Version 10.7.0.3 (Axon
Instruments, CA, USA). I–V curves were fitted with
the equation y = g(Vm – Vrev)/((1 + exp[(Vm – V1/2)
/K])). Activation and steady-state inactivation (SSI)
curves were fitted with the Boltzmann equation y = 1/
(1 + exp[(Vm – V1/2)/K]), where y is the normalized
current or conductance at a given holding potential,
Vm is the membrane potential, Vrev is the reversal
potential, V1/2 is the potential at which half of the
channels are activated, and K is the slope factor.
Immunofluorescence and imaging
Immunocytochemistry
To investigate Nav1.5 subcellular localization, we
performed immunocytochemistry on transiently
transfected RNCs. Two days after transfection,
RNCs were fixed with cold acetone at −20°C
(10 min), washed three times with PBS, and per-
meabilized with blocking buffer (1% BSA, 0.5%
Tx100 and 10% normal goat serum in PBS) for
30 min at room temperature. Primary antibodies
diluted 1:100 in incubation buffer (1% BSA, 0.5%
Tx100 and 3% goat serum in PBS) were applied
overnight at 4°C. We used the following primary
antibodies: mouse anti-FLAG (Sigma) to detect
FLAG-Nav1.5 and rabbit anti-GFP (Thermo
Fisher, G10362) to detect GFP-Nav1.5. Then, cells
were washed twice with PBS and incubated for
45 min at room temperature with AlexaFluor sec-
ondary antibodies (goat anti-rabbit 405 (Thermo
Fisher Scientific)) diluted 1:200 in incubation buf-
fer. We stained the nuclei with DAPI or NucRed
dead 647 ReadyProbes Reagent (2 drops/mL,
Thermo Fisher Scientific). Mounting medium
(EMS shield with Dabco; EMS, PA, USA) was
added to preserve fluorescence signals.
Proximity ligation assay
To determine whether two proteins were close in situ,
we performed PLAs using the Duolink® Starter Kit
Mouse/Rabbit (Sigma) following the manufacturer’s
instructions. We transiently transfected COS cells
with pcDNA3.1-S-tag-SCN5A-WT, -WT NTD and
Δ26 NTD. Forty-eight hours after transfection, we
fixed them with acetone at −20°C for 10 min. The
cells were washed three times with PBS before they
were permeabilized with blocking buffer (1% BSA,
0.5% Tx100 and 10% goat serum in PBS) for 30 min
at room temperature. Cells were incubated with pri-
mary antibodies diluted in incubation buffer (1%
BSA, 0.5% Tx100, and 3% goat serum in PBS) over-
night at 4°C. We used the following primary antibo-
dies: rabbit-anti-S-tag (for S-tagged NTD, 1:100,
Abcam, ab180958) and mouse anti-calmodulin
(1:100, Merck, 05–173); or mouse anti-S-tag (for
S-tagged NTD, 1:1500, Sigma, SAB2702204) and rab-
bit anti-Nav1.5 (1:150, generated by Pineda, Berlin).
After washing the cells 3X with PBS, we incubated
them with anti-rabbit PLUS and anti-mouse MINUS
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PLA probes (1 hour at 37°C) diluted in Duolink®
incubation buffer (1:200; Sigma), followed by three
washes with PBS. We followed the manufacturer’s
instructions for probe ligation and signal amplifica-
tion. Duolink® in situ mounting medium with DAPI
was added to stain cell nuclei and preserve fluores-
cence signals.
Image acquisition and post-acquisition analysis
Confocal images were obtainedwith an inverted laser-
scanning microscope (LSM 880, ZEN 2.1, Zeiss,
Oberkochen, Germany) with a Plan-Apochromat
63X/1.40 Oil DIC objective. We collected COS cell
images in the confocal mode and analyzed them
with the Duolink® ImageTool (Sigma) following the
manufacturer’s instructions. RNC images were col-
lected in the Airyscan super-resolution mode with
the pinhole set at 1.25 Airy unit, pixel size was
35 × 35 nm.We used ZEN 2.1 software for processing
raw Airyscan data, and the IMARIS coloc tool
(IMARIS 9.3.1 software, Bitplane, Zürich,
Switzerland) to quantify the colocalization between
signals of two channels within the predefined ROI
(region of interest, defined as the cell area). We set
an automatic threshold per channel. If the automatic
threshold could not be defined, we set the threshold
at 30%.
Data and statistical analysis
Data are represented as means ± SEM and are
compared to the wild-type condition unless other-
wise indicated. Statistical significance was calcu-
lated with two-tailed Student’s t-test if data were
normally distributed, by the Mann–Whitney
U-test if data were not, and by one-way ANOVA
resp. Kruskal–Wallis when comparing more than
two groups (Prism version 7.04; GraphPad, CA,
USA). We considered a p-value <0.05 to indicate
a statistically significant difference.
Results
Clinical description of the new NaV1.5 variant
Y87C in BrS patients
We identified the novel missense variant
c.260A>G (Y87C) in exon 2 of the SCN5A gene
in two family members of the Russian proband
family and present their pedigree chart in
Supplementary Figure 1A. We found this Y87C
variant neither in 150 ethnically matched controls
nor in the public database gnomAD (https://gno
mad.broadinstitute.org/). This substitution
occurred at a highly conservative position of the
NTD of Nav1.5 (Supplementary Figure 1D).
Three independent in silico tools predicted that
Y87C has a deleterious effect on protein function.
In the absence of functional data Y87C was quali-
fied as a Class III (variant of unknown signifi-
cance, VUS) variant.
The 49-year-old male proband (II.2) and his
eldest son of 23 years (III.2) had a characteristic
spontaneous Brugada pattern on their ECGs
(Supplementary Figure 1B). His younger 13-year-
old son (III.3) has not shown any syncope or
Brugada pattern on his ECG (Supplementary
Figure 1 C), and did not undergo genetic testing
yet. The proband’s father (I.2) was unavailable; at
the last report (age 65) he reported no syncope
history. His granddaughter (IV.1) as well as his
mother (I.2) have a normal ECG and no
complaints.
The proband was asymptomatic without history
of syncope or family history of sudden cardiac
death. His ECG revealed a permanent spontaneous
Brugada pattern, first-degree atrioventricular block
(PR-interval up to 240 ms), and a negative T-wave
in the V1 lead (Supplementary Figure 1B).
During 9 years of follow-up, the proband repeat-
edly complained of chest pain after alcohol con-
sumption. Consequently, he was hospitalized
several times with an initial diagnosis of acute
myocardial infarction (MI), as his ECG showed
an increasing elevation of the ST-segment; how-
ever, his ECGs never showed dynamic changes
specific to MI, and troponin elevation or any
other biochemical MI markers were never
detected. His ECG went back to the usual
Brugada-like shape within 1–2 days after alcohol
abstinence. Proband underwent detailed clinical
examination, and the only extracardiac complaint
was endogenous depression for which he required
medication for many years.
The eldest son of the proband had
a spontaneous Brugada pattern similar to his
father’s. He had no syncope history. During 9
years of follow-up, he remained sober and physi-
cally active.
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Neither the proband nor his eldest son took any
anti-arrhythmic medication or received any inter-
vention. Taking into account the functional
results, the Y87C variant was re-classified to
Class IV (Likely pathogenic).
NaV1.5 Y87C and R104W negatively regulate WT
channel function, but R121W does not
To investigate the consequences of the Y87C variant
on Nav1.5 function, we used the patch-clamp techni-
que to record the sodium current INa of these chan-
nels.We transiently transfected TsA-201 cells with the
Nav β1-subunit and 100% Nav1.5 WT or Y87C, or
with 50% WT and either 50% empty vector or 50%
Y87C to mimic the heterozygous state of the patients
(Figure 1). TsA-201 cells were selected because they
are easy to handle in electrophysiological experiments.
In the homozygous state, the Y87C peak-current
density was 65.9 ± 9.5% smaller than WT (Figure
1a,b,d), while the half-maximal activation potential
(V1/2) of the Y87C activation curve shifted
5.9 ± 1.3% in the depolarized direction. Inactivation
did not shift compared with WT (Figure 1c, Table 1).
In the heterozygous state, co-expressing WT with
Y87C led to a significant INa peak-current decrease
of 25.1 ± 11.0% when compared with WT + empty
vector (Figure 1d). Taken together, these data show
that cells expressing only Y87C channels conduct less
whole-cell sodium current than those expressing WT
channel, which the shift in activation curve only partly
explains. Moreover, Y87C channels exert a DNE over
WT channels, as WT + Y87C conduct ~50% less INa
than WT + empty vector (Figure 1d).
We compared the Y87C variant with the R104W
and R121W variants, which were reported to also
exert a DNE on WT channel function [10]. Both
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Figure 1. The newly identified BrS-associated Nav1.5 variant Y87C exerts dominant-negative effect over WT channels. (a)
Representative whole-cell INa traces recorded from TsA-201 cells transiently transfected with 100% WT Nav1.5, 50% WT + 50%
empty vector, 100% Y87C, or 50% WT + 50% Y87C. (b) Current density-voltage relationships of the four listed conditions. (c) Steady-
state inactivation (SSI, left) and activation (right) relationships obtained using the Boltzmann equation. Whole-cell patch clamp
protocols are given under the respective curves. (d) Peak current densities of each group under unsaturated conditions. Peak current
density of WT + Y87C is significantly lower than that of WT + empty vector, indicating that Y87C exerts a dominant-negative effect
over WT channels. Values pertaining to the biophysical properties are shown in Table 1. Data are presented as mean ± SEM. One-
way ANOVA. *, p < 0.05. Other p values in (D): WT vs. WT + empty vector, p = 0.0002; WT vs. Y87 C, p < 0.0001; WT vs. WT + Y87 C,
p < 0.0001.
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(Figure 2a,b), unlike Y87C (Figure 1a,b). In the het-
erozygous state, co-expressing WT + R104W
decreased INa peak-current density by ~55% com-
pared to WT + empty vector, but no significant
difference was observed between INa from WT +
R121W and WT + empty vector (Figure 2d). The
V1/2 of the activation curves of the different hetero-
zygous conditions did not differ (Figure 2d, Table 2).
In summary, Nav1.5 Y87C and R104W but not
R121W negatively regulate WT channel function.
Variant expression and glycosylation are reduced
compared to WT, but channel-ER colocalization
does not change in variant conditions
To investigate the mechanisms underlying the
reduced or undetectable INa conducted by Y87C,
R104W, and R121W compared to WT Nav1.5
channels, we investigated protein expression at
the cell surface and in whole-cell lysates from
TsA-201 cells expressing the aforementioned WT
or variant channels. TsA-201 cells were chosen
based on their high transfection efficiency and
since electrophysiological recordings on these
cells are easy to perform. WT band intensities
were normalized to 1 (Figure 3). We observed
a relative reduction in Nav1.5 variant protein
expression compared to WT, both overall and at
the cell surface as shown by biotinylation experi-
ments on transfected TsA-201 cells (Figure 3).
Interestingly, only the high-molecular-weight
band intensities are reduced both overall and at
the surface (Figure 3b,e), suggesting that the var-
iant channels are not glycosylated as well as WT
channels [28,29]. mRNA expression of variants
and WT did not differ in transfected TsA-201
cells (Supplementary figure 2).
To assess the intracellular localization of these
variants in a more native cell model, we
transfected rat neonatal cardiomyocytes (RNC)
with calreticulin-DsRed ER marker and WT or
variant Nav1.5 channels and imaged the cells on
a confocal microscope with Airyscan (Figure 4a).
In the homozygous condition, we did not observe
any differences in colocalization of WT or variant
channels with ER (Figure 4c). Note that in the
examples given in Figure 4a, more Nav1.5 variant
signal seems to colocalize with ER than WT, but
quantification of all experimental data shows no
difference (Figure 4c). To mimic the heterozygous
condition, we transfected RNC with GFP-WT and
FLAG-tagged variant channels, in addition to cal-
reticulin-DsRed (Figure 4b). Again, we did not
observe any difference in colocalization of WT
channels with the ER marker in the presence of
WT or variant channels (Figure 4d).
Taken together, the reduced peak INa density of
Y87C, R104W, and R121W compared to WT
channels (Figure 1d, 2d) correlates with
a reduction in surface and overall expression of
fully glycosylated variant channels.
NaV1.5 WT NTDs are within interacting distance
to NaV1.5 WT full-length channels
To explain how someNTD variants can confer aDNE
while others cannot, it is essential to know that the
dominant-negative effect is thought to depend on
channel dimerization [30]. Based on the observation
that co-expressing the NTD with full-length WT Nav
1.5 increases sodium current [10], we investigated the
possibility that the Nav1.5 NTD interacts with full-
length channels. We performed PLAs on COS cells
transfected with full-length WT channels and WT
NTDs to assess if the Nav1.5 NTD is within interact-
ing distance with the whole-length channel in situ
(Figure 5a). In a PLA, two proteins of choice are
labeled with specific primary antibodies to which
Table 1. Biophysical properties of sodium currents conducted by wild-type and Y87C Nav1.5 channels. Peak sodium current (INa)
densities are extracted from the respective IV curves. WT, wild type. Empty v., emtpy vector. Data are presented as mean ± SEM and
are compared to wild-type values. *, p < 0.05; **, p < 0.01; **, p < 0.005; ***, p < 0.001; ****, p < 0.0005. Numbers of cells are
indicated in parentheses.
INa density Steady-state inactivation Activation
pA/pF k V1/2 (mV) k V1/2 (mV)
Nav1.5 WT −94.8 ± 9.3 (n = 8) 5.1 ± 0.1 (n = 17) −76.4 ± 0.7 (n = 17) 7.7 ± 0.3 (n = 10) −22.5 ± 1.0 (n = 10)
Y87C −28.9 ± 4.5 (n = 11)**** 5.1 ± 0.2 (n = 12) −75.2 ± 0.6 (n = 12) 9.4 ± 0.3 (n = 11)*** −16.6 ± 0.8 (n = 11)***
WT + empty v. −51.1 ± 13.5 (n = 9)*** 5.0 ± 0.1 (n = 14) −75.6 ± 0.6 (n = 14) 8.2 ± 0.2 (n = 10) −19.6 ± 1.1 (n = 10)
WT + Y87C −26.0 ± 4.3 (n = 8)**** 5.2 ± 0.2 (n = 10) −75.7 ± 0.8 (n = 10) 8.9 ± 0.3 (n = 8)** −19.3 ± 0.6 (n = 8)*
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secondary antibodies with probes are allowed to bind.
If the proteins of interest are within 40 nm from each
other, the probes can be ligated, and two circle-
forming DNA oligonucleotides will be allowed to
bind. The final amplification step includes fluores-
cently labeled nucleotides; as such, each red dot repre-
sents two proteins of interest that are very close
together. COS cells were the cell line of choice for
these experiments considering their relatively high
cytoplasm volume. Figure 5b shows that WT NTDs
are within 40 nm to full-length WT channels. These
results suggest that indeed the Nav1.5 WT NTD can
interact with full-length WT Nav1.5.
CaM binds to NaV1.5 NTD
To explain why the R121W does not exert a DNE
while Y87C and R104W do, we hypothesized that the
N-terminal domain around position R121 must con-
tain a binding site for a yet-unknown protein. We
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Figure 2. Nav1.5 variant R104W but not R121W exerts dominant-negative effect over WT channels. (a) Representative whole-cell INa
traces recorded from TsA-201 cells transiently transfected with 100% WT Nav1.5, 50% WT + 50% empty vector, 100% R104W, 50%
WT + 50% R104W, 100% R121W or 50% WT + 50% R121W. (b) Current density-voltage relationships of the listed conditions. (c)
Steady-state inactivation (SSI, left) and activation (right) curves obtained using the Boltzmann equation. Patch clamp protocols are
given under the respective curves. (d) Peak current densities of each group under unsaturated condition. Peak current density of WT
+ R104W is significantly lower than that of WT + empty vector, indicating the dominant-negative effect of R104W over WT channels.
Values pertaining to the biophysical properties are shown in Table 2. Data are presented as mean ± SEM. ***, p < 0.001.
Table 2. Biophysical properties of sodium currents conducted by wild-type, R104W, and R121W Nav1.5 channels. Peak sodium
current (INa) densities are extracted from the respective IV curves. WT, wild type; emtpy v., empty vector. Data are presented as mean
± SEM and are compared to wild-type values. *, p < 0.05; **, p < 0.01; **, p < 0.005; ***, p < 0.001; ****, p < 0.0005. ND, non-
detectable. Numbers of cells are indicated in parentheses.
INa density Steady-state inactivation Activation
pA/pF k V1/2 (mV) k V1/2 (mV)
Nav1.5 WT −86.6 ± 11.4 (n = 9) 5.3 ± 0.2 (n = 11) −73.2 ± 0.5 (n = 11) 6.6 ± 0.2 (n = 9) −22.7 ± 0.6 (n = 9)
R104W ND (n = 7) n/a n/a n/a n/a
R121W ND (n = 7) n/a n/a n/a n/a
WT + empty v. −38.4 ± 3.4 (n = 5)**** 4.8 ± 0.1 (n = 5) −74.4 ± 0.9 (n = 5) 6.9 ± 0.3 (n = 5) −20.0 ± 0.2 (n = 5)*
WT + R104W −23.1 ± 4.6 (n = 9)**** 5.4 ± 0.2 (n = 11) −75.9 ± 0.5 (n = 11)* 7.5 ± 0.3 (n = 7)* −19.5 ± 0.7 (n = 7)**
WT + R121W −46.9 ± 3.4 (n = 12)**** 5.2 ± 0.2 (n = 6) −72.5 ± 1.3 (n = 6) 7.4 ± 0.3 (n = 10) −20.3 ± 0.5 (n = 10)**
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1.5 N-terminus based on the following observations.
Firstly, calmodulin binds the NTD of the voltage-
gated calcium channel Cav1.2 at two different sites
[16,17], and plays a role in C-terminal dimerization of
Cav1.2 [31,32] andNav1.5 [33]. Secondly, theNTDs of
Nav1.5 and Cav1.2 both contain a highly conserved
sequence consisting of the residues PIRRA (Figure 6a,
b), herein the PIRRA motif. In Cav1.2, this motif
interacts with calmodulin and calmodulin-binding
protein 1 (CaBP1) [16,34]. Moreover, several
sequence fragments of the Cav1.2 and Nav1.5 NTDs
have a high level of sequence identity [35] (Figure 6b).
Firstly, we used the CaM target database to
predict the CaM-Nav1.5 NTD binding affinity
(Figure 6d) [16,36,37]. Consecutive high binding
scores suggest a CaM binding site, which occurs at
amino acid residues ~94-~108 (Figure 6d), which
includes R104, but not Y87 and R121. We then
processed the Nav1.5 NTD with a peptide SPOTS
array to biochemically assess CaM binding to 15-
amino-acid-long N-terminal peptides (Figure 6c).
We identified a putative CaM-binding sequence
comprising 26 amino acids (residues 80–105,
Figure 6c), which overlapped with the computa-
tional prediction (Figure 6d) and included Y87
and R104, but not R121.
To validate the putative CaM-binding sequence, we
determined whether CaM is close to the Nav1.5 NTD
in situ by performing proximity ligation assays (PLA)
on COS cells transfected with S-tagged Nav1.5 WT
NTD or Δ26 NTD, in which the 26-amino-acid-long
putative CaM binding site was deleted (Figure 7a).
A dot in these images indicates that a Nav1.5 NTD
andCaMarewithin 40 nmof each other.Weobserved
that much more CaM proteins are in close proximity
to Nav1.5 WT NTD than to Δ26 NTD (Figure 7b).
Next, we performed CaM pull-down assays at
the physiological Ca2+ concentration of 100 nM to
determine if CaM binds to the Nav1.5 WT NTD
(Figure 7c). Lysates from TsA-201 cells transfected
a
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WT        Y87C     R104W   R121W   
Figure 3. Surface protein expression of all three BrS variants is decreased compared to WT in transfected TsA-201 cells. (a)
Representative western blot of three independent experiments with whole-cell lysates of TsA-201 cells transiently transfected
with WT, Y87C, R104W, or R121W Nav1.5 (n = 3). Solid and open black arrowheads represent the high- and low-molecular-weight
bands, respectively. Full blots are shown in Supplementary Figure 3. (b-c) Relative protein band intensity of input high- and low-
molecular-weight bands normalized to Na/K ATPase. Nav1.5 WT band intensities are normalized to 1 in each condition. (d)
Representative western blot of the surface biotinylated fraction of transfected TsA-201 cells (respective whole-cell lysates are
shown in (A)). Solid and open gray arrowheads represent the high- and low-molecular-weight, respectively. (e-f) Relative intensity of
surface high- and low-molecular-weight bands normalized to Na/K ATPase. Nav1.5 WT band intensities are normalized to 1. Data are
presented as mean ± SEM. *, p < 0.05; ***, p < 0.001. ANOVA: p < 0.0001 (a), non-significant (b), p = 0.0267 (c), non-significant (d).
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with Nav1.5 NTD constructs were exposed to
CaM-coated or uncoated control sepharose beads.
Proteins bound to the beads were eluted and
visualized on western blots. The well-established
CaM interaction partner CaMKII served as posi-
tive control [38] (Figure 7c). We observed that the
CaM-coated beads but not the control beads had
pulled-down NTD proteins, suggesting that CaM
specifically binds to the NTD.
Moreover, deleting the aforementioned 26
amino acids (Δ26) from the NTD greatly reduced
CaM binding in all tested conditions with cell
lysate amounts containing 60 µg, 180 µg, and
540 µg protein (Figure 7d), suggesting that these
26 amino acids comprise a CaM binding site. As
less than 540 µg protein did not saturate the wes-
tern blots (Figure 7c), we chose to use 360 µg
protein for the following pull-down experiments.















































Figure 4. WT and variant channel-ER colocalization is similar in homo- and heterozygous conditions. (a) Airyscan microscopy images
of RNCs transiently co-transfected with WT or variant flag-Nav1.5 (green) and the ER marker calreticulin-DsRed2 (red), representing
homologous conditions. Nuclei are stained with DAPI (blue). Right column: merged images. (b) Airyscan microscopy images of RNCs
transiently co-transfected with GFP-Nav1.5 WT (green), flag-Nav1.5 WT or variants (not shown), and calreticulin-DsRed2 (red). Right
column: merged images; nuclei are stained with DAPI (blue). (c) Quantification of Nav1.5-ER colocalization in homozygous conditions.
Colocalization is defined as percentage of Nav1.5 signal area colocalizing with ER signal area within predefined ROI. (d) Quantification
of colocalization of WT-Nav1.5 with ER in the presence of variants, representing heterozygous conditions. Cell areas in which Nav1.5
and ER colocalize are: WT, 57.4 ± 9.3%; Y87C, 54.0 ± 12.6%; R104W, 75.1 ± 9.5%; and R121W, 47.9 ± 10.5%. Scale bar, 10 µm. Data
are presented as mean ± SEM. Groups were not significantly different.
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Taken together, these results suggest that CaM
interacts with the Nav1.5 WT NTD and that this
interaction largely depends on 26 residues of theNTD.
R121W but not Y87C And R104W weaken the NaV
1.5 NTD-CaM interaction
We next investigated CaM binding to the WT,
Y87C, R104W, R121W, and Δ26 Nav1.5 NTDs
using CaM pull-downs. We observed that the
binding of WT, Y87C, and R104W NTDs to the
CaM beads was similar, while R121W and Δ26
NTDs did so to a much lesser extent (~-50%)
(Figure 8a,b). These results suggest that Δ26 and
R121W impair the Nav1.5 NTD-CaM interaction,
but Y87C and R104W do not. Please note that
R121W is outside of the predicted 26 amino acid
CaM-binding region (Figure 3c), suggesting CaM
may bind two NTD sites.
Based on the notion that the homologous Cav1.2
NTD contains a similar arginine to Nav1.5-R121, both
residing in the PIRRA motif [16,34], we next deter-
mined if mutating the Cav1.2 homologous site
R144W also weakens the Cav1.2-CaM interaction.
We performed CaM pull-down assays with lysates
from TsA-201 cells transfected with Cav
1.2-R144W-NTD or Cav1.2-WT-NTD (Figure 9).
Bands were normalized to endogenous CaMKII, the
positive control of the CaM pull-down assay. Cav
1.2 WT bands were additionally normalized to 1.
We found that CaM binds to Cav1.2 WT NTD, con-
sistent with previous reports [16,17], while R144W
partly abolished the interaction with CaM by
66.0 ± 7.7% (Figure 9a,b), which is expected as R144
lies within one of the two N-terminal sequences pre-
viously associated with CaM binding [16].
In summary, in the Nav1.5 NTD, both the pre-
dicted 26 amino acid sequence and R121 are
involved in CaM binding. Similarly, the Cav1.2
NTD R144 site is homologous to R121 and
required for CaM binding.
Discussion
In this work, we demonstrated that CaM binds the
N-terminus of Nav1.5, which resembles CaM bind-
ing to the NTD of Cav1.2 [16,17,31,32]. This inter-
action seems to be crucial for the dominant-
negative effect, in which a Nav1.5 NTD variant
identified in BrS patients negatively regulates wild-
type channel function. Specifically, we identified in
probands of a Russian family, the new natural
Brugada syndrome variant Y87C in the Nav1.5
NTD and showed that Y87C-Nav1.5 channels
exert a DNE on WT channels when co-expressed
in TsA-201 cells.
We also showed that natural BrS variants in the
Nav1.5 NTD do not consistently show a DNE: Y87C
and R104W do, while R121W does not. To explain
this discrepancy, we showed that CaM binding to Nav
1.5 NTDpartly depends on amino acids 80–105 (a 26-
AA-long sequence) or residue R121. Thus, the DNE
of the tested NTD BrS variant correlates with CaM-
NTD interaction strength. Moreover, all tested BrS
variant full-length channels show reduced expression
and glycosylation at the cell surface than wild-type
BA negative control Nav1.5-WT +




















Nav1.5 - Nav1.5 NTD
Figure 5. CaM interacts with Nav1.5 NTD. (a) Representative Duolink® PLA images of COS cells transiently transfected with WT
S-tagged Nav1.5 NTD. Red dot signals were generated when full-length WT Nav1.5 is within 40 nm of WT or variant NTD. Nuclei
stained with DAPI in blue. Scale bar, 10 µm. (b) Quantitative analysis of the PLA signals. Data are presented as mean ± SEM. **,
p < 0.005.
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channels. We schematically summarize the functional
consequences of the BrS variants in Figure 10.
CaM binds to the NaV1.5 N-terminal domain
We established the CaM-Nav1.5 NTD interaction
based on in silico modeling, SPOTS assay, pull-
down assays and in situ hybridization assays using
heterologous expression systems transiently
expressing Nav1.5 NTD constructs (Figures 6, 7).
Deleting amino acids 80–105 and mutating R121
both abolish the CaM-Nav1.5 NTD interaction,
while mutations R104W and Y87C do not affect
CaM-NTD interaction (Figures 7, 8). Whether
CaM interacts with the Nav1.5 NTD in vivo, and
whether this interaction is involved in Nav1.5
dimerization, remain open questions. We showed
in COS cells that the Nav1.5 NTD is within inter-
acting distance (<40 nm) of full-length Nav1.5
(Figure 5); thus, we may hypothesize that Nav1.5
channels interact in vivo in a CaM-mediated man-
ner. We showed that the natural BrS variant
R121W in the Nav1.5 homologous PIRRA motif
diminishes interaction of NTD with full-length
Nav1.5 in pull-down experiments. The same was
observed when deleting amino acids 80–105,
which suggests that CaM may have two binding
sites, potentially one for each lobe. At the Nav1.5
DII-III linker, distinct CaM C- and N-lobe binding
sites have already been described [15,39].
Unfortunately, technical issues have prevented us
from confirming in proximity ligation assays that
a
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Figure 6. CaM is predicted to bind Nav1.5 NTD. (a) Sequence alignment of Nav1.5 and Cav1.2 NTDs used in this study (https://www.ebi.ac.
uk/Tools/msa/clustalo/). The Nav1.5 BrS variants studied here are marked with red stars. The 26-AA-long predicted CaM Nav1.5 NTD
binding site is marked with a dashed black line. Solid black line [17,56], black stars [36], and pink star [16] indicate CaM-binding sites in the
Cav1.2 NTD. Residue homologies are scored as follows: asterisk (*), identical; colon (:), strongly similar properties; stop (.), weakly similar
properties. Residue color codes: red: small; blue: acidic; magenta: basic; green: hydroxyl, sulfhydryl, amine. (b) Secondary structure
prediction of Nav1.5 and Cav1.2 NTDs (http://bioinf.cs.ucl.ac.uk/psipred/). β-strands (yellow), α-helices (pink), and coil regions (gray) are
indicated. Grey boxes indicate sequences with a high degree of homology (https://blast.ncbi.nlm.nih.gov). (c) Normalized interaction
between Nav1.5 NTD peptides and CaM based on peptide SPOTS arrays. The signal amplitude of the first peptide (AA 1–15) is centered at
AA position 8 and the last (AA 112–126) at 121. The interaction was normalized to the strongest signal correspondent to the IQ motif in
Nav1.5 C-terminal domain. Predicted CaM-binding site is marked in red; peptides containing the PIRRAmoif in blue. (d) Sequence of Nav1.5
NTD with predicted CaM-binding scores. Scores are normalized on a scale from 0 to 9. A sequence with consecutively high scores suggests
the presence of a CaM-binding site. The 26 amino acid sequence containing the putative CaM-binding site based on peptide SPOTS arrays
(c) is underlined in red. The PIRRA motif is underlined in blue. The amino acids corresponding to the Y87 C, R104 W, and R121 W variants
are given in red. (e) Topology of the Nav1.5 α-subunit. Red line indicates location of predicted CaM-binding sequence, blue line indicates
PIRRA motif location. Panel (e) adapted from Abriel et al [6].








































































Figure 7. CaM binds to Nav1.5 N-terminal domain. (a) Representative Duolink® PLA images of COS cells transiently transfected with
S-tagged WT NTD, Δ26 Nav1.5 NTD, or empty vector as a negative control. Red dots were generated when endogenous CaM and
NTD were less than 40 nm apart. Nuclei are stained blue with DAPI. Scale bar, 10 µm. (b) Quantitative analysis of the PLA signals. (c)
Representative western blot of three independent CaM pull-down experiments performed with TsA-201 cells transiently transfected
with S-tagged WT or Δ26 Nav1.5 NTD. In the latter, the 26 amino acids comprising the predicted CaM-binding sequence (Figure 6)
were deleted. We used different amounts of cell lysate (60, 180, 540 µg) to detect CaM-interaction under non-saturating conditions.
Full blots are shown in Supplementary Figure 4. (d) Relative protein band intensity of pulled-down Nav1.5 NTDs. The protein band
intensities are normalized to the 540 µg Nav1.5 WT NTD condition. Compared to WT, the pulled-down Δ26 NTD relative protein band
intensity reduced by ~5%, ~12%, or ~75% with 60, 180, or 540 µg protein lysate, respectively. Data are presented as mean ± SEM. *,




























Figure 8. Nav1.5 variant R121W weakens the interaction of Nav1.5 NTD with CaM. (a) Representative western blot of three
independent CaM-Nav1.5 NTD pull-down experiments using cell lysate equivalent to 360 µg protein per condition from TsA-201
cells transfected with WT, Y87C, R104W, R121W or Δ26 Nav1.5 NTD. Full blots including negative controls are shown in
Supplementary Figure 5. (b) Nav1.5 NTD protein band intensities of are normalized to the average WT value. Data are presented
as mean ± SEM. ***, p < 0.001 (Mann-Whitney). Kruskal-Wallis p = 0.0084.
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the aforementioned N-terminal variants inhibit
interaction between Nav1.5 full-length channels
and/or N-terminal constructs. Thus, future
research efforts should be directed toward specify-
ing the intricacies of the CaM-Nav1.5 NTD bind-
ing and toward the potential role of the Nav1.5
NTD in Nav1.5 dimerization.
Considering potential roles for CaM at the Nav1.5
NTD, known effects of CaM binding to the NTD and
CTD of Cav1.2, and to the CTD of Nav1.5 may
provide valuable insights. At the CTD of Nav1.5 and
Cav1.2, CaM is involved in channel dimerization
[31–33], while CaM binding to the Cav1.2 CTD
and NTD affects calcium-dependent inactivation
[31–33]. At the Nav1.5 C-terminal IQ motif, CaM
interaction reduces the late sodium current [40], and
affects voltage-dependence of activation in
a calcium-dependent manner [33,41,42]. Whether
similar mechanisms come to play in CaM binding
to the Nav1.5 NTD remains unknown.
Given the multiple CaM binding sites at a full-
length Nav1.5 channel, the stoichiometry of Nav
1.5:CaM remains to be determined. Previous FRET
experiments have shown a 1:1 stoichiometry [39];
however, the Nav1.5 N-terminus was not included
in the respective Nav1.5 peptides.
Besides CaM, other Nav1.5 NTD binding part-





























Figure 9. The R144W mutation in Cav1.2 weakens the Cav1.2 NTD-CaM interaction. (a) Representative western blot of three
independent CaM-Cav1.2 NTD pull-down experiments performed with 360 µg TsA-201 cell lysate. Full blots are shown in
Supplementary Figure 6. (b) Relative protein band intensities of Cav1.2 NTD were normalized to endogenous CaMKII and then
to WT. Data are presented as mean ± SEM. ***, p < 0.001.
Figure 10. Working model of the CaM-Nav1.5 NTD interactions and Nav1.5 variants in homozygous conditions. Nav1.5 WT channels
(green) are readily trafficked from the ER to the plasma membrane, and conduct a normal INa density (gray). Y87C (red) or R104W
(blue) channel proteasomal degradation (red) is increased and INa is decreased compared to WT, while exerting a DNE on variant
channels. R121W channels (pink) do not conduct a detectable sodium current and do not exert a DNE on wild-type channels. CaM
(black) interacts with WT, Y87C, and R104W channels but not with R121W.
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the DNE. α1-syntrophin has been shown to bind
the three C-terminal residues of Nav1.5 and serine-
20 of the Nav1.5 NTD [43,44], where it plays a role
in the chaperone effect of the NTD, in which co-
expressing the Nav1.5 NTD with full-length Nav1.5
(or with Kir2.1 and −2) leads to higher INa (or IK1)
compared to full-length channel expression alone
in CHO cells [43]. Together with the notion that
α1-syntrophin is a critical mediator for Nav1.5
anchoring to the cytoskeleton [45–47], these find-
ings suggest that α1-syntrophin may too mediate
channel–channel interactions and/or clustering.
However, the α1-syntrophin-binding residue ser-
ine-20 is not affected by any of the NTD con-
structs used in this study.
The dominant-negative effect of NaV1.5 variants
Contrary to a previous report [10], we show that
R121W full-length channels do not exert a DNE
on wild-type channels, while R104W and the
newly identified variant Y87C do (Figure 1, 2).
We also could not reproduce the positive shift in
activation of the sodium current when R104W and
R121W channels are co-expressed with WT chan-
nels as Clatot et al. observed [10]. These discre-
pancies may lie in experimental conditions (TsA-
201 cells and untagged SCN5A constructs in our
study versus HEK293 cells and GFP-tagged
SCN5A constructs used by Clatot et al. [10]).
Experiments in hiPSCs from variant-carrying BrS
patients or in mouse models heterozygous for
R104W, R121W, or Y87C could shed light on
this discrepancy in a more native or in vivo system.
Although our data do not give direct evidence
for Nav1.5-Nav1.5 dimerization, we may hypothe-
size that the observed DNE of R104W and Y87C
BrS variants depends on Nav1.5 NTD dimerization
based on the following observations. Firstly, partly
abolishing the CaM interaction by mutating R121
correlated with the absence of the DNE (Figure 2).
Secondly, CaM plays a role in Nav1.5 and Cav1.2
dimerization at their C-termini [16,31–34]. This
may be extrapolated to the Nav1.5 NTD but
remains to be investigated. Thirdly, Nav1.5 dimer-
ization mediated by 14-3-3 at the DI-II linker has
been shown to be crucial for Nav1.5 DNE as inhi-
biting 14-3-3 binding abolished the DNE [12]. In
addition to 14-3-3, Mercier et al. reported that the
sodium channel β1-subunit was required for the
DNE [28]. Indeed, the DNE of Nav1.5 loss-of-
function variants may involve many more mole-
cular determinants. Partly underlying this gap in
knowledge is the notion that research groups func-
tionally characterizing Nav1.5 variants rarely co-
express WT with variant channels; therefore, lit-
erature on the Nav1.5 DNE is relatively scarce [8].
How CaM, 14-3-3, the β1-subunit, and potential
other Nav1.5 interacting proteins interdependently
or independently establish the DNE, and which
known Nav1.5 variants do and do not exert
a DNE, are exciting venues for future research.
The hypothesis that channel di- or multimeriza-
tion underlies the DNE of variant Nav1.5 is further
indirectly supported by the multimerization of
other voltage-gated channels. Cav1.2 channels in
the heart for instance have been shown to be
functionally and physically coupled in a CaM-
and Ca2+-mediated manner [48]. This coupling is
increased by ß-adrenergic stimulation [49]. In the
brain, functional coupling has been shown for BK
and Cav1.3 channels, and cooperative gating has
been suggested to play a role in short-term mem-
ory [50,51]. Lastly, voltage-gated proton channels
that are expressed in many organisms and tissues
are also shown to gate cooperatively [52–54]. The
body of knowledge regarding channel–channel
interactions however is still in its infancy, and
the roles of these interactions in the pathogenesis
of cardiac arrhythmias remain to be uncovered.
On a side note, transfecting TsA-201 cells with
R104W or R121W alone does not yield any sodium
current while transfecting with Y87C does (Figure
1a, 2a). This may be related to the fact that exchan-
ging an arginine for a tryptophan (RW) constitutes
a larger structural change than exchanging
a tyrosine for a cysteine (YC). The mechanisms
underlying the absence or presence of conductivity
of these variants and the role of structural changes
therein however remain to be determined.
Decreased NaV1.5 protein expression and its
subcellular localization
We observed a reduction in protein expression of
the fully glycosylated form of Y87C, R104W, or
R121W channels compared to wild-type, both at
the cell surface and in whole-cell lysates, whereas
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expression of the core-glycosylated form did not
change (Figure 3). Functionally, a reduction in
fully glycosylated Nav1.5 channels has been shown
to change voltage-dependency of Nav1.5 [55]; how-
ever, we have not observed this effect in our own
functional experiments (Figures 1,2). We investi-
gated whether this could be explained by variants
retaining wild-type channels in the ER, but in the
presence of variant channels, wild-type channels
showed similar degrees of co-localization with the
ER (Figure 4). mRNA expression was the same
between groups (Supplementary figure 2), indicat-
ing that variability in transfection rate, gene tran-
scription, or mRNA processing do not underlie the
differences in protein expression. Rather, we expect
that the reduction in fully glycosylated variant Nav
1.5 may be the result of increased proteasomal
degradation. Mercier et al. have shown that the
fully glycosylated band represents Nav1.5 channels
that have followed the pathway from ER to Golgi
and the plasma membrane, whereas core-
glycosylated channels are transported from the ER
straight to the plasma membrane [28]. Thus, we
hypothesize that fully glycosylated BrS variant chan-
nels having passed through the Golgi seem more
susceptible to proteasome-mediated degradation.
The underlying mechanisms however remain
unclear and offer exciting venues for future study.
Conclusion
Based on our experimental data, we can conclude that
the novel naturally occurring Y87C variant is likely
directly linked to the BrS phenotype of the probands.
Moreover, we show novel calmodulin-binding sites at
the Nav1.5 N-terminal domain, in conjunction with
its putative role in the dominant-negative effect of
natural Brugada syndrome variants. These results
need to be validated in vivo and the intricacies of
CaM-Nav1.5 NTD binding remain to be unraveled.
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